# DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
> **ANDA217027** · Abbreviated New Drug Application (Generic) · Sponsor: GRANULES · Approved 2023-01-23
## Drug
- **FDA Application Number:** ANDA217027
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
- **Generic name:** DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE
- **Active ingredients:** AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
- **Dosage form:** CAPSULE, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** GRANULES
- **Manufacturer:** Granules Pharmaceuticals Inc.
- **First approval:** 2023-01-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217027)
---
*AI Analytics · CC0 1.0*